4.4 Review

Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death A Systematic Review and Meta-analysis

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study

William Murk et al.

Summary: This study utilized United States health claims data to investigate the complications of COVID-19, confirming and providing risk estimates for numerous disorders associated with the disease, such as viral pneumonia, respiratory failure, acute kidney failure, and sepsis. These findings can offer guidance for prognosis, treatment decisions, and patient counseling.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

Review Clinical Neurology

Psychological and neuropsychiatric implications of COVID-19

E. B. Mukaetova-Ladinska et al.

Summary: The rapid spread of COVID-19 has led to a significant healthcare burden globally, requiring urgent interventions such as epidemiological measures and efficient treatment. Additionally, the mental health impact of the outbreak on patients, families, healthcare workers, and the general public should not be underestimated.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy

Valentina Orlando et al.

Summary: This study identified conditions and diseases that make people more vulnerable to SARS-CoV-2 infection, supporting decision-makers in identifying high-risk individuals and adopting preventive measures to minimize the spread of further epidemic waves.

PLOS ONE (2021)

Article Biochemistry & Molecular Biology

Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

Nicolas Hoertel et al.

Summary: This study suggests that the use of antidepressants in patients hospitalized for COVID-19 may be associated with a lower risk of death or intubation. Antidepressants such as fluoxetine, paroxetine, escitalopram, venlafaxine, and mirtazapine showed significant associations with reduced risk. Further research in the form of double-blind controlled randomized clinical trials is recommended.

MOLECULAR PSYCHIATRY (2021)

Article Psychiatry

A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders

Ahmad A. Toubasi et al.

Summary: This meta-analysis found that pre-diagnosis with mental disorders is associated with an increased risk of COVID-19 mortality and severity. Patients with schizophrenia, schizotypal, and delusional disorders had higher mortality rates compared to those with mood disorders. It is recommended to prioritize vaccination for patients with mental disorders alongside healthcare providers and the elderly.

PSYCHIATRY RESEARCH (2021)

Article Psychiatry

Association of Psychiatric Disorders With Mortality Among Patients With COVID-19

Katlyn Nemani et al.

Summary: The study found that patients with schizophrenia spectrum disorders were significantly associated with mortality in COVID-19 cases, while patients with mood disorders and anxiety disorders were not.

JAMA PSYCHIATRY (2021)

Article Medicine, General & Internal

A Phenome-Wide Association Study (PheWAS) of COVID-19 Outcomes by Race Using the Electronic Health Records Data in Michigan Medicine

Maxwell Salvatore et al.

Summary: This study identified pre-existing conditions associated with COVID-19 outcomes, such as hospitalization, ICU admission, and mortality. It also highlighted the importance of targeted screening for specific vulnerable populations and revealed differences in disease prognosis among different racial groups.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Psychiatry

The impact of COVID-19 on subthreshold depressive symptoms: a longitudinal study

Y. H. Liao et al.

Summary: The study found that the COVID-19 pandemic had a significant negative impact on symptoms of depression, anxiety, and insomnia. Mental health outcomes fluctuated during the pandemic and were somewhat alleviated as community transmission decreased. Measures like resilience and regular exercise can help mitigate the risk of mental health symptoms during this public health crisis.

EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2021)

Letter Psychiatry

Homeless mentally ill people and COVID-19 pandemic: The two-way sword for LMICs

Sujita Kumar Kar et al.

ASIAN JOURNAL OF PSYCHIATRY (2020)

Article Environmental Sciences

Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain

Beatriz Poblador-Plou et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Geriatrics & Gerontology

Outcomes of Nursing Home COVID-19 Patients by Initial Symptoms and Comorbidity: Results of Universal Testing of 1970 Residents

Olive Tang et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)

Article Medicine, General & Internal

Analysis of the Risk Factors for Mortality in Adult COVID-19 Patients in Wuhan: A Multicenter Study

Man Li et al.

FRONTIERS IN MEDICINE (2020)

Review Clinical Neurology

Impact of COVID-19 pandemic on mental health in the general population: A systematic review

Jiaqi Xiong et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Review Endocrinology & Metabolism

Obesity in patients with COVID-19: a systematic review and meta-analysis

Yi Huang et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Article Public, Environmental & Occupational Health

What Factors Increase the Risk of Complications in SARS-CoV-2-Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization

Chen Yanover et al.

JMIR PUBLIC HEALTH AND SURVEILLANCE (2020)

Article Medicine, General & Internal

Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study

Wonjun Ji et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2020)

Article Immunology

C-reactive protein and response to lurasidone in patients with bipolar depression

Charles L. Raison et al.

BRAIN BEHAVIOR AND IMMUNITY (2018)

Article Medicine, Research & Experimental

Editorial (Thematic Issue: Mood Disorders and General Medical Comorbidities: Shared Biology and Novel Therapeutic Targets)

Roger S. McIntyre et al.

CURRENT MOLECULAR MEDICINE (2016)

Article Psychiatry

Bipolar Disorder and Inflammation

Joshua D. Rosenblat et al.

PSYCHIATRIC CLINICS OF NORTH AMERICA (2016)

Review Public, Environmental & Occupational Health

The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013

Zachary Steel et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)

Review Immunology

Depression and immunity: A role for T cells?

Andrew H. Miller

BRAIN BEHAVIOR AND IMMUNITY (2010)

Article Clinical Neurology

Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

Elisa Brietzke et al.

JOURNAL OF AFFECTIVE DISORDERS (2009)

Review Psychiatry

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

M. Bryant Howren et al.

PSYCHOSOMATIC MEDICINE (2009)

Article Medicine, General & Internal

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher et al.

BMJ-BRITISH MEDICAL JOURNAL (2009)

Article Psychiatry

Mood disorders: cardiovascular and diabetes comorbidity

Wayne S. Fenton et al.

CURRENT OPINION IN PSYCHIATRY (2006)